A phase II study of apatinib, a highly selective inhibitor of VEGFR-2, in patients with metastatic solid tumors without standard treatment options

出版年份 2016 全文链接

标题

作者

关键词

出版物

Volume 27, Issue suppl_6, Pages -

出版商

Oxford University Press (OUP)

发表日期

2017-02-04

DOI

10.1093/annonc/mdw368.16

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now